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SIGNIFICANCE
This study collected clinical data for 87 patients with inhe-
rited ichthyoses, and analysed serum levels of 25-hydroxy-
vitamin D3 (25(OH)D3) and parathyroid hormone. These 
measurements were performed before routine substitution 
of vitamin D in ichthyoses. Vitamin D deficiency and in-
sufficiency was highly prevalent in this study cohort. Less 
than 10% of the patients had sufficient vitamin D levels. 
Moreover, vitamin D deficiency was related to the clinical 
severity of scaling. Thus, this study supports our recent 
guidelines for ichthyoses, which recommend screening for 
and substituting of vitamin D deficiency.
Data on vitamin D status of patients with inherited 
ichthyosis in Europe is scarce and unspecific concer-
ning the genetic subtype. This study determined se-
rum levels of 25-hydroxyvitamin D3 (25(OH)D3) in 
87 patients with ichthyosis; 69 patients were addi-
tionally analysed for parathyroid hormone. Vitamin D 
deficiency was pronounced in keratinopathic ichthyo-
sis (n = 17; median 25(OH)D3: 10.5 ng/ml), harlequin 
ichthyosis (n = 2;7.0 ng/ml) and rare syndromic sub-
types (n = 3; 7.0 ng/ml). Vitamin D levels were reduced 
in TG1-proficient lamellar ichthyosis (n = 15; 8.9 ng/ml), 
TG1-deficient lamellar ichthyosis (n = 12; 11.7 ng/ml), 
congenital ichthyosiform erythroderma (n = 13; 12.4 
ng/ml), Netherton syndrome (n = 7; 10.7 ng/ml) and 
X-linked ichthyosis (n = 8; 13.9 ng/ml). In ichthyosis 
vulgaris 25(OH)D3 levels were higher (n = 10; 19.7 
ng/ml). Parathyroid hormone was elevated in 12 pa-
tients. Low 25(OH)D3 levels were associated with high 
severity of scaling (p = 0.03) implicating scaling as a 
risk factor for vitamin D deficiency. Thus, this study 
supports our recent guidelines for ichthyoses, which 
recommend screening for and substituting of vitamin 
D deficiency. 
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Inherited ichthyoses are monogenic disorders of corni-fication, which are caused by genetic defects affecting 
the function of the epidermal barrier (1) and associated 
with increased transepidermal water loss (2). Homeostatic 
repair processes compensating for transepidermal water 
loss result in clinically pronounced scaling and hyperke-
ratosis and are associated with either epidermal hyperpro-
liferation or with retention hyperkeratosis (1–3). Marked 
inflammation induced by barrier defects and by epidermal 
repair mechanisms is typical for most types of autosomal 
recessive congenital ichthyosis (ARCI), keratinopathic 
ichthyosis (KPI) including epidermolytic ichthyosis (EI) 
and superficial epidermolytic ichthyosis (SEI), and many 
syndromic forms, such as Netherton syndrome (NTS). 
In humans, the epidermis is the major source of 
vitamin D production. It is synthesized photochemically 
from 7-dehydrocholesterol, which is an intermediate in 
the late steps of epidermal biosynthesis of cholesterol. 
Under the influence of UVB light 7-dehydrocholesterol is 
photolysed in a non-enzymatic reaction to previtamin D3 
bound in the vessels of the dermis to vitamin D binding 
protein. From there it is transported to the liver, where 
it is transformed into 25-hydroxyvitamin D3 (25(OH)
D3; cholecalciferol; vitamin D3). This metabolite is later 
transformed in the kidneys into 1α,25-dihydroxy-vitamin 
D3 (calcitriol), which is the biologically active form 
of vitamin D3 (4). The typical human manifestation of 
severe vitamin D deficiency is osteomalacia (5). Nume-
rous medical conditions, ranging from cardiovascular 
problems to metabolic syndrome, certain types of cancer, 
proneness to infections, Alzheimer’s disease and atopic 
dermatitis have recently been linked to vitamin D defi-
ciency. Vitamin D3 acts in humans as a prohormone and 
is relevant for innate and adaptive immunity (6). CAMP, 
encoding for the antimicrobial peptide cathelicidin, is 
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a target gene, and its expression in human skin can be 
increased by topical application of vitamin D derivatives, 
such as calcipotriol (7, 8).
To date, data on vitamin D status in European patients 
with ichthyosis is scarce, and mostly unspecific concer-
ning the genetic subtype. Single cases or a few selected 
patients have been studied. Manifestations of rickets after 
treatment with oral retinoids in children with lamellar 
ichthyosis have been reported (9–11). Furthermore, one 
study has systematically evaluated vitamin D status in a 
European cohort of patients with ichthyosis. This study 
also established that the severity of scaling acts as an 
independent risk factor, possibly by providing a physical 
blockade for ultraviolet (UV) light penetration (12). In an 
Indian cohort of patients with ichthyosis an association 
between highly pigmented skin (type IV and type V skin) 
and vitamin D deficiency was found (13).
It remains unknown which type of ichthyosis is the 
strongest risk factor for vitamin D deficiency. This obser-
vational, prospective monocentric study of 87 characte-
rized patients with hereditary ichthyosis focussed especi-
ally on genetically defined ARCI. The study determined 
25(OH)D3 serum levels in patients without vitamin D 
substitution. The study also analysed parathyroid hormone 
(PTH) to exclude alterations of vitamin D due to abnormal 
levels of PTH and to analyse whether patients with vitamin 
D deficiency show secondary hyperparathyroidism. The 
study also evaluated the importance of the severity of 
scaling as a possible independent risk factor in ichthyosis. 
MATERIALS AND METHODS
Study design 
This is a prospective monocentric study, performed at the Depart-
ment of Dermatology of the University Hospital of Muenster and 
its reference centre for genetic skin diseases. The centre was a 
member of the Network for Ichthyoses and Related Keratinization 
disorders (NIRK).
All investigations were carried out within the framework of 
NIRK, and approval was provided by the institutional review 
board (2XTrau1). In total, the study enrolled 87 patients, who 
underwent a careful clinical examination in the University Hospital 
of Muenster, Germany, by 2 expert dermatologists (H.T. and V.O.). 
All patients were clinically studied regarding erythema, scored 
from absent to severe (0–3; 0: absent; 1: mild; 2: moderate; 3: 
severe). In order to characterize the severity of scaling we adapted 
a 5-point physician general assessment, as used in a clinical trial 
on lamellar ichthyosis (R00002CR301(ORF), www.clinicaltrial-
sregister.eu). This Scaling and Cornification Score in Ichthyosis 
(SCSI) encompasses the extent of cornification as well as affected 
body surface area (BSA) as published recently (Table SI1) (14).
Genetic analysis
The patients underwent further diagnostic procedures to analyse 
the genetic subtypes of ichthyosis. Consequently, all patients diag-
nosed with ichthyosis vulgaris (IV) were analysed for filaggrin 
(FLG) gene mutations by restriction enzyme analysis as well as 
typical ultrastructural and/or immunohistological features (14, 
15). In patients with X-linked ichthyosis (XLI), steroid sulphatase 
deficiency was confirmed by biochemical methods, that either 
included direct STS activity testing in blood or detection of typical 
metabolite profiles, such as high levels of oxysterol sulfates in 
serum (14,16). In patients with ARCI, skin biopsies were routi-
nely taken, and cryosections were tested for transglutaminase-1 
(TG1) deficiency by in situ monitoring of TG1 activity (17). In 
addition, genomic DNA from peripheral blood lymphocytes was 
isolated from most patients with ARCI, and PCR amplification, 
Sanger sequencing or NGS methods were performed (18). For the 
group with KPI, histology and/or ultrastructural characterization 
were performed to underline KRT1, KRT10 or KRT2 mutations 
(19). In patients with NTS the clinical diagnosis was confirmed 
by demonstrating LEKTI deficiency in immunohistology and by 
molecular analysis with detection of SPINK5 mutations (1). For 
all remaining cases, including keratitis ichthyosis deafness (KID) 
syndrome, genetic analyses were performed. 
Serum analysis
To determine vitamin D status (serum concentrations of 25(OH)
D3) and PTH levels, blood samples were collected from patients 
by venipuncture and centrifuged immediately. Sera were aliquot-
ed, stored at −70°C and analysed in a routine hospital laboratory 
(Center for Laboratory Medicine, University Hospital Muenster) 
using commercially available immunoassays. Concentrations 
of 25(OH)D3 were determined using a competitive chemilumi-
nescence immunoassay (CLIA, DiaSorin Deutschland, Dietzen-
bach, Germany) on a Liason automated analyser. The intra- and 
inter-assay variabilities were < 4.0% and < 7.0%, respectively. 
Concentrations of intact parathormone were determined using a 
direct CLIA (Siemens, Eschborn, Germany) on Immulite 2000 
automated analyser. The intra- and inter-assay variabilities were 
< 4.2% and < 8.8%. 
Vitamin D deficiency was defined as a serum level of 25(OH)
D3 < 10 ng/ml and vitamin D insufficiency as a level of 10–29.9 
ng/ml. A normal and sufficient level was defined as ≥ 30 ng/ml. 
Toxicity levels are ≥ 100 ng/ml. Hyperparathyroidism was defined 
as serum PTH level of ≥ 65 pg/ml. While vitamin D level was 
measured in all 87 patients, PTH levels were determined in only 
69 patients. Insufficient PTH values were distributed evenly over 
all genetic subtypes.
Statistical analysis
All data analyses were performed with SPSS version 26, software 
for statistical analysis, for Windows and Excel. Continuous para-
meters were shown as median and range [minimum – maximum], 
and categorical parameters as absolute and relative frequencies. 
Group comparisons of continuous parameters were performed by 
Mann–Whitney U or Kruskal–Wallis test (> 2 groups). Correla-
tions were assessed by Spearman’s rank correlation coefficient. 
Inferential statistics were intended to be exploratory and were in-
terpreted accordingly. Two-sided p-values ≤ 0.05 were considered 
statistically significant.
RESULTS
Clinical data of the cohort
In the study cohort of 87 patients with ichthyosis, 10 
patients had been diagnosed with IV, 8 with X-linked 
ichthyosis (XLI), 42 with ARCI, with 2 of them having 
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KPI, and 7 NTS (Table I). Other diagnoses included 
KID syndrome (n = 1), Keratosis linearis-ichthyosis 
congenita-sclerosing keratoderma (KLICK) syndrome 
(n = 1), and peeling skin disease (n = 1). In the group 
with ARCI, 12 patients showed mutations in transgluta-
minase 1 (TGM1) (transglutaminase 1 (TG1) - deficient 
ARCI) and 22 patients had mutations in NIPAL4 (n = 7), 
ALOXE3 (n = 5), ALOX12B (n = 3), ABCA12 (n = 2), 
PNPLA1 (n = 3), or CYP4F22 (n = 2). From a clinical 
point of view, criteria can be used to distinguish between 
lamellar ichthyosis (LI) and congenital ichthyosiform 
erythroderma (CIE) within the group with ARCI: patients 
with LI were characterized by coarse lamellar scaling, 
CIE was defined by pronounced erythema and finer 
scaling. Fifteen patients in the current study cohort were 
categorized as having LI, and 13 patients as CIE. In 8 
cases of the ARCI group the exact molecular cause could 
not be established, but the presence of TGM1 mutations 
had been excluded (TG1-proficient ARCI). In this group, 
2 patients clinically showed LI and 6 patients had CIE. 
Patient age ranged from 1 to 86 years, with a median of 
18 years. There were slightly more females (n = 48) than 
males (n = 39).
Vitamin D and parathyroid hormone levels
In the study cohort, 32 patients showed 25(OH)D3 serum 
values regarded as vitamin D deficiency (median 7.0 
ng/ml [7.0–9.2]), 49 subjects displayed insufficiency 
(median 15.2 ng/ml [10.2–29.2]) and 6 patients had 
vitamin D levels within the normal range (median 32.4 
ng/ml [30.0–35.8]). The median 25(OH)D3 level of the 
entire study cohort was 12.6 ng/ml. Since normal serum 
25(OH)D3 levels vary between 30.0 and 100.0 ng/ml, 
the data from this study generally showed that ichthy-
osis-affected individuals have a certain risk of either 
pronounced deficiency or at least insufficiency of 
vita min D. A seasonal comparison of vitamin D levels 
indicated somewhat higher levels of 25(OH)D3 in the 
summer (median 13.25 ng/ml [7.0–35.8]) compared 
with measurements in the winter half-year (median 12.4 
ng/ml [7.0–24.6]). This difference was not statistically 
significant (p = 0.272) and does not seem to be relevant 
from a clinical point of view. 
The median serum PTH level for the total study 
cohort was 40.2 pg/ml. Most patients were within 
the normal range of 10.0–65.0 pg/ml. Of note, 12 
patients showed increased PTH levels associated with 
deficient or insufficient vitamin D values (median 
7.0 ng/ml [7.0–16.8]). These patients did not report 
any symptoms of hyperparathyroidism. They were 
not specifically checked for associated diseases by 
an endocrinologist; however, routine blood and se-
rum parameters were within the normal range. Only 
one patient with IV showed a reduced PTH level 
(8.2 pg/ml). The vitamin D level of this patient was 
insufficient (21.4 ng/ml), regular blood and serum 
parameters were normal. 
A slightly negative correlation was found between 
25(OH)D3 and PTH levels (rs=–0.47). The distribu-
tion of vitamin D and PTH levels in relation to the 
severity of scaling are shown in Fig. 1. While higher 
SCSI scores were significantly associated with lower 
vitamin D levels (p = 0.03), the high SCSI scores 
were linked to increasing PTH level (p = 0.04). The 
extent of erythema tended to be associated with 
decreasing 25(OH)D3 and increasing PTH levels; 
however, the association was not significant and not 
strong (p = 0.32 and p = 0.17) (Table SI1). 
Vitamin D status of ichthyosis subtypes 
The distribution of 25(OH)D3 levels for different 
genetic subtypes of ichthyosis is shown in Fig. 2. The 
best vitamin D status was found in patients with a 
mild ichthyosis phenotype, such as IV. For this group 
(n = 10; 19.7 ng/ml [13.3–32.1]) only 50% of patients 
were vitamin D deficient. In XLI, usually presenting 
with a mild or moderate ichthyosis phenotype, 5 out of 
8 patients exhibited deficient 25(OH)D3 levels (medi-
an 13.9 ng/ml [7.0–35.1]). Lowest 25(OH)D3 values 








Ichthyosis vulgaris IV [146700] 10 (11.5) 19.7
X-linked ichthyosis XLI [308100]   8 (9.2) 13.9
ARCI ARCI 30 (34.5)*  
  LI   8.9
    ARCI due to ALOX12B mutations 3 
    ARCI due to NIPAL4 mutations   7 
    ARCI due to PNPLA1 mutations 3 
    ARCI unclassified (TG1-proficient) 2 
    ARCI due to TG1 deficiency 12 (13.8) 11.7 
  CIE 12.4 
    ARCI due to ALOXE3 mutations 5 
    ARCI due to CYP4F22 mutations 2 
    ARCI unclassified (TG1-proficient) 6 
  HI   7.0 
    ARCI due to ABCA12 mutations 2 
Netherton syndrome NTS [256500] 7 (8.0) 10.7
Miscellaneous 3 (3.5)   7.0
  Keratitis ichthyosis deafness KID [602450, 148210] 1 
  KLICK syndrome  KLICK [601952] 1 
  Peeling skin disease PSS1 [270300] 1 
Keratinopathic ichthyosis (KPI) 17 (19.5) 10.5
  EI (KRT10 mutations) EI [113800] 5 
  EI (KRT1 mutations) 1
  SEI (KRT2 mutations) SEI [146800] 1 
  KPI unclassified 10 
Age: median 18 years (1–86)
Sex: 48 females, 39 males
Four clinical subgroups (group 1: mild ichthyoses: ichthyosis vulgaris (IV), X-linked 
ichthyosis (XLI); group 2: lamellar ichthyosis (LI), congenital ichthyosiform 
erythroderma (CIE), Harlequin ichthyosis (HI), including transglutaminase 1 (TG1)-
deficient and proficient autosomal recessive congenital ichthyosis (ARCI) patients; group 3: 
Netherton syndrome (NTS) and other syndromic and rare subtypes; group 4: 
keratinopathic ichthyosis (KPI)).
*This number excludes TG1-deficient ARCI.
EI: epidermolytic ichthyosis; KID: keratitis-ichthyosis-deafness syndrome; KLICK: 
keratosis linearis with ichthyosis congenita and sclerosing keratoderma; PSS1: peeling 
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were observed in patients with KPI (n = 17; median 10.5 
ng/ml [7.0–21.3]) (Fig. 2). In this group only one patient 
showed a vitamin D status that was higher than 20 ng/ml. 
A pronounced deficiency was observed in patients with 
TG1-deficient lamellar ichthyosis (n = 12; median 11.7 
ng/ml [7.0–32.6]) and NTS (n = 7; median 10.7 ng/ml 
[7.0–30.6]). In each of these groups, only one patient had 
a sufficient vitamin D level. The heterogeneous group 
of TG1-proficient ARCI, including LI with ALOX12B 
or NIPAL4 mutations and patients with CIE, but exclu-
ding HI patients showed a low vitamin D level (n = 28; 
median 11.15 ng/ml [7.0–35.8]). LI with other than 
TGM1 mutations usually show a milder 
phenotype compared with TG1-deficient 
lamellar ichthyosis (median SCSI: 2 vs 
3). How ever, the median vitamin D level 
in this group was lower than in the TG1-
deficient group (8.9 vs 11.7 ng/ml). In the 
group with ARCI, most severe vitamin 
D deficiency was observed in HI. Both 
patients with HI had a severity score of 4 
points and showed the lowest vitamin D 
levels (both 7.0 ng/ml). PTH levels were 
the highest measured in our cohort (109 
and 169 pg/ml) (Fig. 3).
From a clinical point of view, the 
cohort was differentiated into 4 groups: 
group 1 (mild ichthyoses: IV, XLI); 
group 2 (LI, CIE, HI; including TG1-
deficient and -proficient ARCI patients); 
group 3 (NTS and other syndromic and 
rare subtypes); group 4 (KPI) (Table I). A notable diffe-
rence was found between these 4 groups regarding vita-
min D status (17 vs 10.95 vs 9.5 vs 10.5 ng/ml; p =  0.01). 
The difference between these groups concerning PTH 
levels was not significant (35.3 vs 45.75 vs 44.1 vs 36.3 
ng/ml; p = 0.11). There was no strong correlation between 
serum vitamin D levels and age (rs=–0.229) (Fig. S1
1).
DISCUSSION
Data on vitamin D status in inherited ichthyoses in Eu-
rope is rare. A study of 53 patients in France revealed that 
more than 80% of patients did not have an optimal 
vitamin D status. The study showed ichthyosis 
severity, dark skin, and winter/spring seasons as 
independent risk factors (12). In a recent Spanish 
study on malnutrition in 50 patients with ichthyosis 
vitamin D serum levels below the reference value 
were detected in only 22% of patients. However, 
20% of patients had already received supplements, 
and the authors refer to the geographical location 
of their cohort. The authors could not show a cor-
relation between insufficient vitamin D values and 
disease severity or undernutrition (20). To study 
the vitamin D status in ichthyosis, the current study 
further distinguished between genetic and clinical 
subtypes. Of note, 16 out of 17 patients with KPI 
had a highly severe vitamin D insufficiency or de-
ficiency, and 1 patient had a moderate insufficiency. 
A large proportion of patients with TG1 deficiency 
with pronounced scaling and hyperkeratosis, as 
well as those with NTS with variable and (in most 
cases) mild to moderate scaling exhibited a marked 
deficiency of vitamin D. Vitamin D deficiency was 
present, but less significant, in the group with ARCI 
(23 out of 28 cases). Finally, vitamin D deficiency 
was less pronounced in clinically mild types of 
Fig. 2. Vitamin D levels in genetic subtypes of ichthyosis. Keratinopathic 
ichthyosis (KPI), Harlequin ichthyosis (HI), lamellar ichthyosis (LI), Netherton 
syndrome (NTS) and other syndromic ichthyoses show lowest vitamin D values, 
patients with milder types of ichthyosis (ichthyosis vulgaris (IV), X-linked 
ichthyosis (XLI)) only have a moderate insufficiency. Reference value for vitamin D 
sufficiency ≥30 ng/ml. CIE: congenital ichthyosiform erythroderma; HI: Harlequin 
ichthyosis; ARCI: autosomal recessive congenital ichthyosis.
Fig. 1. Vitamin D, parathyroid hormone (PTH) levels and Scaling and Cornification 
Score in Ichthyosis (SCSI). (a) Boxplots of vitamin D (25(OH)D3) levels for different degrees 
of the Scaling and Cornification Score in Ichthyosis (SCSI) showing highest 25(OH)D3 levels in 
patients with low SCSI. Reference value for vitamin D sufficiency: ≥30 ng/ml. (b) Boxplots of 
PTH levels for different degrees of SCSI. High SCSI scores are associated with increased PTH 
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ichthyosis, such as IV and XLI. Nonetheless, even for 
IV it was established that half of the patients with FLG 
mutations had vitamin D deficiency. This is in contrast 
to a population study from Denmark and Germany, in 
which 9 compound heterozygous or homozygous carriers 
of FLG mutations had even higher 25(OH)D3 concentra-
tions than the normal population (21). This discrepancy 
is surprising, but the clinical status of the 9 IV patients 
in the Danish population study was not described, and 
they were possibly less severely affected by scaling than 
the 10 patients in the current study cohort. 
Similar to a previous French study (12), the current 
study observed that higher SCSI scores were associated 
with lower vitamin D levels (Fig. 1a). The study group 
included 7 patients with NTS who had a markedly lower 
median vitamin D level. These patients did not have se-
vere scaling, but severe erythema (mean and median: 2). 
Concerning the severity of scaling, a median SCSI of 1 
was observed for these patients compared with a median 
SCSI of 2 in other patients in the current cohort. These 
findings imply that erythroderma or skin inflammation 
may also contribute to vitamin D deficiency. Of note, 
a positive correlation was observed between SCSI and 
PTH levels, which is in line with an American study (22).
The influence of skin pigmentation was not analysed 
within the current study group, as the study included only 
patients with fair skin types (primarily type II and III). 
Data from patients with black skin types in India sup-
port the notion that ichthyosis of black skin represented 
a much higher risk for vitamin D deficiency (13). 
To examine whether extremely high levels of PTH in 
patients with HI are a random finding, and to analyse 
possible causes for such high levels through screening of 
larger cohorts of HI for vitamin D serum levels and 
further endocrinological parameters are necessary.
In the literature there is a report on improvement 
of scaling after vitamin D supplementation in 
patients with ichthyosis and vitamin D deficiency 
(23). Since we have not systematically followed up 
our patients after beginning a vitamin D substitu-
tion, we need further studies to evaluate whether 
vitamin D substitution not only prevents secondary 
diseases but also has direct effects on scaling and 
inflammation of the skin. 
The protective role of vitamin D is not yet fully 
understood. Although there are no international 
guide lines concerning vitamin D substitution as a 
prophylaxis against COVID-19 the Robert Koch 
Institute in Germany recommends vitamin D 
substitution for patients with deficient levels and 
higher risk for or active COVID-19 infections. 
This recommendation is based on the knowledge 
of an anti-inflammatory and immunomodulatory 
potential of vitamin D (24, 25). However, a causality 
is not proven, and a deficiency may be caused by 
inflammation and severe disease (26–28). There is 
still a need for clinical trials and studies analysing 
links between vitamin D deficiency and pathogenesis or 
worsening of disorders, especially infectious diseases. 
We conclude that all patients with ichthyosis are at risk 
of having a deficient or insufficient level of vitamin D. 
This risk seems most pronounced in patients with KPI. 
Although we did not compare our data with an age- and 
sex-matched healthy control cohort, it is known that vita-
min D deficiency is common in the German population. 
Data from the Robert Koch Institute revealed vitamin D 
deficiency in 30.2% of German adults between 18 and 
79 years of age. Sufficient values (defined as > 50 nmol/l) 
were detected in 38.4% of the study population (29). An-
other study that examined vitamin D levels in patients ≤ 16 
years with juvenile idiopathic arthritis detected sufficient 
serum values (defined as ≥ 30 ng/ml) in only 16.0% of 
healthy controls (30). Of note, in our cohort only 6.9% 
were measured as having sufficient serum levels. 
The current study showed that the degree of scaling 
and cornification represents a risk factor for vitamin D 
deficiency. Avoidance of outdoor activity in patients with 
severe scaling and/or erythema and associated hypo-
hidrosis may be considered as an additional explanation 
for low vitamin D status and minor differences in the 
values between the seasons. 
In summary, measurement of vitamin D levels should 
be recommended in patients with ichthyoses, especially 
for individuals with severe scaling and cornification or 
inflammatory forms. This recommendation does not refer 
to distinct age groups. Monitoring of PTH levels and 
further endocrinological diagnostic may be considered 
only in patients with extremely low vitamin D status. 
Vitamin D supplementation for patients with insufficient 
Fig. 3. Parathyroid hormone (PTH) levels in genetic subtypes of ichthyosis. 
PTH levels in genetic subtypes of ichthyosis, with highest PTH levels in patients 
with Harlequin ichthyosis. Normal range for PTH levels: 10–65 pg/ml. IV: ichthyosis 
vulgaris; XLI: X-linked ichthyosis: LI: lamellar ichthyosis; CIE: congenital 
ichthyosiform erythroderma; HI: Harlequin ichthyosis; ARCI: autosomal recessive 
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or deficient vitamin D serum levels is recommended to 
prevent secondary diseases. 
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